Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06906302 · ClinicalTrials.gov registry record · NA

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

A NA study of Intimate Partner Violence (IPV), sponsored by Boston University.

Recruiting
Registry status
NA
Development phase
172
Enrollment target
3
Study locations

NCT06906302 is a NA study of Intimate Partner Violence (IPV) that is actively recruiting participants, run by Boston University. The registered enrollment target is 172 participants, below the 568-participant average among 5 other Intimate Partner Violence (IPV) trials with a reported enrollment target (70% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06906302, a NA study of Intimate Partner Violence (IPV), is actively recruiting participants, sponsored by Boston University.

RECRUITING
Registry status
NA
Development phase
172 participants
Enrollment target
3
Study locations

Study Summary

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health. Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

Interventions

  • BEHAVIORAL RISE
  • BEHAVIORAL Advocacy-based ECAU

Study Locations (3)

Massachusetts

  • VA Boston Healthcare System - Boston

Minnesota

  • VA Minneapolis Healthcare System - Minneapolis

Pennsylvania

  • VA Philadelphia Healthcare System - Philadelphia

Trial Details

FieldValue
Enrollment Target 172 participants
Start Date 2025-09-15
Est. Completion 2030-01
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT06906302

The ClinicalTrials.gov registry entry for NCT06906302 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 568-participant average among 5 other Intimate Partner Violence (IPV) trials with a reported enrollment target (70% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intimate Partner Violence (IPV) appearing as the primary indexed condition, and to 2 interventions - of which RISE is the first listed.

NCT06906302 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Minnesota, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06906302 about?

NCT06906302 is a clinical study titled "RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV". This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and...

What is the current status of trial NCT06906302?

This trial is currently recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2025-09-15. Estimated completion is 2030-01.

What conditions does trial NCT06906302 study?

This clinical trial studies the following conditions: Intimate Partner Violence (IPV).

What interventions are being tested in trial NCT06906302?

The interventions under investigation include: RISE (BEHAVIORAL), Advocacy-based ECAU (BEHAVIORAL).

Who is sponsoring clinical trial NCT06906302?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06906302 being conducted?

This trial has 3 study locations across Massachusetts, Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intimate Partner Violence (IPV)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.